My friend Mara Kardas-Nelson wrote an excellent piece in the Mail & Guardian on Brazil’s continuing fight against intellectual property laws that make the cost of second and third line HIV treatment unaffordable for public health programmes. Darunavir and Raltegravir (key third line drugs) each cost $5000 per year in Brazil… and there are 6000 …
Brazil’s continuing fight against intellectual property laws Read More »
In the 2013 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection (2013 Guidelines), the World Health Organization (WHO) takes a welcomed step in recommending that people living with HIV everywhere be offered a standard of antiretroviral treatment and care that is closer to what is available in resource-rich countries. …
When this site first went online, we posted the intro to this article, which I wrote last year… I’ve always intended to post the rest of it but never got around to it. Somehow the text got corrupted, but I hope this is closer to what it should be. The rest of the article will …
Models of community- & patient-delivered HIV and TB services, pt 1, [Repost] Read More »
The Global Network of People Living with HIV (GNP+), the International HIV/AIDS Alliance (the Alliance) and STOP AIDS NOW! (SAN!) have sent out the following request for input on the development of their Community Guide to WHO’s 2013 Consolidated ART Guidelines. Dear fellow community and civil society members, As you may know, WHO recently launched …
Survey for a Community Guide to the 2013 Consolidated ART Guidelines Read More »
Theo Smart interviews Edwin Bernard of the HIV Justice Network The following interview is one of five I conducted at IAS 2013 to gather case studies for an internal document for one on the funders of my trip to the meeting. The funder didn’t need the full interview, but we thought that it was too …
“Key populations* have high burdens of HIV with low access to services — and in way too many countries, they are the last people in line. So when we think about changing the guidelines with increasing access to care, that, it seems to me, is the fundamental issue that we need to address. No one …
Researching the use of ARVs for Treatment *and* Prevention in Key Populations Read More »
Just as the IAS 2013 conference began in Kuala Lumpur, an email arrived from Vancouver stating that the final 2013 International HIV Treatment as Prevention Workshop report and evaluation are now available and can be downloaded here. In addition, all materials related to the 2013 Workshop, including evaluation, photos, and daily summaries, are available at …
2013 International HIV Treatment as Prevention Workshop Report/Materials online Read More »
As the conference opening session would make clear, in some respects, Malaysia’s HIV response has been a model in the region — but cultural and religious sensitivities and taboos constrain it in others. ‘Why Malaysia?’ was a question I heard from more than one researcher at the airport and in the express train into Kuala …
A joint statement from the Global Network of People Living with HIV (GNP+) in partnership with the International HIV/AIDS Alliance (the Alliance) and STOP AIDS NOW(SAN!) issued today has welcomed WHO’s new Consolidated Guidelines on the use of Antiretroviral Drugs for Treatment and Prevention. The joint statement calls on government, multilateral and bilateral agencies, and …
Communities vital to delivery of the new global HIV treatment guidelines Read More »
WHO released 2013 Consolidated Guidelines on the Use of Antiretroviral Drugs for Treatment and Prevention today at the IAS 2013 conference in Kuala Lumpur, which can be downloaded here: Its key points, according to support materials: Treating adults, adolescents and older children earlier – starting ART in all individuals with a CD4 cell count of …